142 related articles for article (PubMed ID: 12461777)
1. Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids.
Roninson IB; Dokmanovic M
J Cell Biochem; 2003 Jan; 88(1):83-94. PubMed ID: 12461777
[TBL] [Abstract][Full Text] [Related]
2. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
3. To kill tumor cells or permanently paralyze them in senescence?
Christov K
J BUON; 2009; 14(2):189-96. PubMed ID: 19650165
[TBL] [Abstract][Full Text] [Related]
4. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
[TBL] [Abstract][Full Text] [Related]
5. Synthetic retinoid CD437 induces cell-dependent cycle arrest by differential regulation of cell cycle associated proteins.
Shyu RY; Lin DY; Reichert U; Jiang SY
Anticancer Res; 2002; 22(5):2757-64. PubMed ID: 12529993
[TBL] [Abstract][Full Text] [Related]
6. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
Holmes WF; Soprano DR; Soprano KJ
J Cell Physiol; 2004 Jun; 199(3):317-29. PubMed ID: 15095280
[TBL] [Abstract][Full Text] [Related]
7. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.
Chang BD; Broude EV; Dokmanovic M; Zhu H; Ruth A; Xuan Y; Kandel ES; Lausch E; Christov K; Roninson IB
Cancer Res; 1999 Aug; 59(15):3761-7. PubMed ID: 10446993
[TBL] [Abstract][Full Text] [Related]
8. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell senescence in cancer treatment.
Roninson IB
Cancer Res; 2003 Jun; 63(11):2705-15. PubMed ID: 12782571
[TBL] [Abstract][Full Text] [Related]
10. Retinoids as chemopreventive agents.
Ralhan R; Kaur J
J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
[TBL] [Abstract][Full Text] [Related]
11. Retinoids and ovarian cancer.
Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ
J Cell Physiol; 2000 Oct; 185(1):1-20. PubMed ID: 10942515
[TBL] [Abstract][Full Text] [Related]
12. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
13. Retinoids in biological control and cancer.
Fields AL; Soprano DR; Soprano KJ
J Cell Biochem; 2007 Nov; 102(4):886-98. PubMed ID: 17902161
[TBL] [Abstract][Full Text] [Related]
14. Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes.
Dokmanovic M; Chang BD; Fang J; Roninson IB
Cancer Biol Ther; 2002; 1(1):24-7. PubMed ID: 12170760
[TBL] [Abstract][Full Text] [Related]
15. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells.
Dedieu S; Lefebvre P
Cell Signal; 2006 Jun; 18(6):889-98. PubMed ID: 16176868
[TBL] [Abstract][Full Text] [Related]
16. Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels.
Offterdinger M; Schneider SM; Grunt TW
J Cell Physiol; 2003 May; 195(2):260-75. PubMed ID: 12652653
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR.
Holmes WF; Soprano DR; Soprano KJ
J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on RAR-beta 2 induction.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
[TBL] [Abstract][Full Text] [Related]
19. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
Jiang T; Soprano DR; Soprano KJ
J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084
[TBL] [Abstract][Full Text] [Related]
20. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model.
El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Apr; 257(2):596-603. PubMed ID: 10198257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
